对甲氧苄啶-磺胺甲恶唑脱敏后成功治疗医院获得性嗜麦芽窄食单胞菌菌血症。
Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.
作者信息
Yilmaz Mesut, Celik Aykut Ferhat, Mert Ali
机构信息
Infectious Diseases and Clinical Microbiology Department, Cerrahpasa Medical Faculty, University of Istanbul, Turkey.
出版信息
J Infect Chemother. 2007 Apr;13(2):122-3. doi: 10.1007/s10156-007-0505-z. Epub 2007 May 8.
PMID:17458682
Abstract
Stenotrophomonas maltophilia has emerged as an important cause of morbidity and mortality in hospitalized patients. Because trimethoprim-sulfamethoxazole (TMP-SMX) remains the most effective drug for the treatment of S. maltophilia infections, desensitization should be considered in patients with hypersensitivity to TMP-SMX.
摘要
嗜麦芽窄食单胞菌已成为住院患者发病和死亡的重要原因。由于复方磺胺甲恶唑（TMP-SMX）仍然是治疗嗜麦芽窄食单胞菌感染最有效的药物，因此对TMP-SMX过敏的患者应考虑进行脱敏治疗。
相似文献
1
Successfully treated nosocomial Stenotrophomonas maltophilia bacteremia following desensitization to trimethoprim-sulfamethoxazole.对甲氧苄啶-磺胺甲恶唑脱敏后成功治疗医院获得性嗜麦芽窄食单胞菌菌血症。
J Infect Chemother. 2007 Apr;13(2):122-3. doi: 10.1007/s10156-007-0505-z. Epub 2007 May 8.
2
Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.甲氧苄啶-磺胺甲恶唑敏感与耐药嗜麦芽窄食单胞菌单菌血症患者的比较：一项10年回顾性研究。
J Microbiol Immunol Infect. 2016 Jun;49(3):378-86. doi: 10.1016/j.jmii.2014.06.005. Epub 2014 Jul 28.
3
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?左氧氟沙星可否替代复方磺胺甲噁唑治疗嗜麦芽窄食单胞菌菌血症？
Antimicrob Agents Chemother. 2014;58(1):581-3. doi: 10.1128/AAC.01682-13. Epub 2013 Oct 14.
4
Stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: an increasing problem.对甲氧苄啶-磺胺甲恶唑耐药的嗜麦芽窄食单胞菌：一个日益严重的问题。
Ann Clin Microbiol Antimicrob. 2006 Sep 18;5:23. doi: 10.1186/1476-0711-5-23.
5
Clinical and Microbiologic Outcomes in Patients with Monomicrobial Stenotrophomonas maltophilia Infections.单一致病菌嗜麦芽寡养单胞菌感染患者的临床和微生物学结局。
Antimicrob Agents Chemother. 2019 Oct 22;63(11). doi: 10.1128/AAC.00788-19. Print 2019 Nov.
6
Clinical outcomes of Stenotrophomonas maltophilia infection treated with trimethoprim/sulfamethoxazole, minocycline, or fluoroquinolone monotherapy.单用复方新诺明、米诺环素或氟喹诺酮治疗嗜麦芽窄食单胞菌感染的临床疗效。
Int J Antimicrob Agents. 2021 Aug;58(2):106367. doi: 10.1016/j.ijantimicag.2021.106367. Epub 2021 May 28.
7
Clinical and microbiological characteristics of patients colonized or infected by Stenotrophomonas maltophilia : is resistance to sulfamethoxazole/trimethoprim a problem?嗜麦芽窄食单胞菌定植或感染患者的临床和微生物学特征：对磺胺甲恶唑/甲氧苄啶耐药是个问题吗？
Rev Inst Med Trop Sao Paulo. 2020 Dec 7;62:e96. doi: 10.1590/S1678-9946202062096. eCollection 2020.
8
Optimizing therapy for Stenotrophomonas maltophilia.优化嗜麦芽窄食单胞菌的治疗方法。
Semin Respir Crit Care Med. 2007 Dec;28(6):672-7. doi: 10.1055/s-2007-996414.
9
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.碳青霉烯类治疗期间革兰阴性菌血症突破发生的临床特征及危险因素
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6673-6678. doi: 10.1128/AAC.00984-16. Print 2016 Nov.
10
Monotherapy with minocycline or trimethoprim/sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.米诺环素或甲氧苄啶/磺胺甲恶唑单药治疗嗜麦芽窄食单胞菌感染。
J Antimicrob Chemother. 2016 Apr;71(4):1071-5. doi: 10.1093/jac/dkv456. Epub 2016 Jan 21.
Zotero 插件